Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

4D Molecular Therapeutics’ Fabry Gene Therapy put on FDA-mandated hold

February 7, 2023 Research and Development

4D Molecular Therapeutics has had its gene therapy programme 4D-310 put on clinical hold by the FDA after adverse side …
News

SPR Therapeutics gains FDA extended approval for pain management system

February 6, 2023 Research and Development

Pain management medical device company SPR Therapeutics has obtained expanded approval from the FDA for its SPRINT Peripheral Nerve System …
News

Australia’s TGA approves psychedelics to treat mental health conditions

February 6, 2023 Research and Development

Australia’s Therapeutic Goods Administration (TGA) has announced its approval of the use of psychedelics to treat certain mental health conditions. …
News

Insilico Medicine opens new R&D facility in Abu Dhabi

February 3, 2023 Research and Development

Hong Kong-based healthtech company Insilico Medicine recently opened its eighth global laboratory in Abu Dhabi.   Utilising Abu Dhabi’s Masdar …
News

Adding veliparib to chemotherapy can extend progression-free survival in in some breast cancer patients

February 1, 2023 Research and Development

It appears that adding veliparib to chemotherapy can extend progression-free survival (PFS) in patients suffering from triple negative breast cancer …
News

NaDeNo’s nanomedicine delivery system inspires hope for peritoneal cancer

February 1, 2023 Research and Development

NaDeNo, a new nanomedicines company and spin-off of the Norwegian science institute SINTEF, has revealed promising results for its cure …
News

Aptar Pharma releases recyclable nasal spray pump

January 31, 2023 Research and Development

US-based drug delivery systems company Aptar Pharma has released its first metal-free, multidose nasal spray. APF Futurity delivers multidose nasal …
News

First Wave BioPharma announces phase 2 trial

January 31, 2023 Research and Development

Clinical-stage biopharmaceutical company, First Wave BioPharma, has announced that it is planning to begin its phase 2 clinical trial of …
News

Ipsen reports CHMP negative review for use of palovarotene in EU

January 27, 2023 Research and Development

Ipsen, a biopharmaceutical company focused on medicines in oncology, rare diseases and neuroscience, have been denied marketing authorisation by the …
News

IsoChemiX develop molecules to speed up R&D process

January 27, 2023 Research and Development

UK-based pharmaceutical drug discovery company IsoChemiX is developing molecules which will have the ability to cut both the time and …
News

AI finds liver cancer drug candidate in only 30 days

January 26, 2023 Research and Development

With most drug discovery and development processes taking years, if not decades, a team of scientists have broken records with …
News

Poxel given EC’s Orphan Drug Designation for rare metabolic disorders

January 25, 2023 Research and Development

Clinical stage biopharmaceutical company Poxel, who focus on developing innovative treatments for chronic, serious diseases with metabolic pathophysiology, has been …
News

TheracosBio’s oral drug approved by FDA for adults with type 2 diabetes

January 24, 2023 Research and Development

TheracosBio has announced that the first oral SGLT2 inhibitor, bexaflilozin, has been approved by the FDA for the treatment of …
News

FDA grants Accelerated Approval for Seagen’s colorectal cancer treatment

January 23, 2023 Research and Development

Seagen Inc has been given FDA Accelerated Approval for its colorectal drug TUKYSA (tucatinib) after reviewing positive data from the …
News

AI and motion capture technology used to monitor movement disorders

January 23, 2023 Research and Development

A team of researchers have been developing a monitoring system to assess the progression of movement disorders. The new technology …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026